Thrombophilia Market Projected to Reach $15.9 Billion in 2023 with a CAGR of 7.5%, Driven by Technological Advancements

DUBLIN, July 26, 2023 /PRNewswire/ -- The "Thrombophilia Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers, and senior management with critical information needed to assess the Thrombophilia market. The market is projected to grow from $14.79 billion in 2022 to $15.90 billion in 2023, with a compound annual growth rate (CAGR) of 7.5%. Furthermore, the market is expected to reach $20.87 billion by 2027, with a CAGR of 7.0%.

Major players in the Thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Mylan N.V., Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC, Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Aspen Insurance Holdings Limited, Sanofi SA, and Eisai Co. Limited.

Reasons to Purchase:

• Gain a comprehensive global perspective with detailed coverage of 50+ geographies.
• Understand the market's response to COVID-19 and how it is responding as the impact of the virus abates.
• Assess the direct and indirect effects of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and the market.
• Measure the influence of high global inflation on market growth.
• Develop regional and country-specific strategies based on localized data and analysis.
• Identify investment opportunities in growth segments.
• Outperform competitors using forecast data and insights into market drivers and trends.
• Understand customer dynamics based on the latest market shares.
• Benchmark performance against key competitors.
• Support internal and external presentations with reliable high-quality data and analysis.

Thrombophilia is a blood disorder characterized by an increased risk of blood clotting in veins and arteries, which can lead to serious health complications such as heart attacks, strokes, kidney failure, and pulmonary embolisms.

The main types of thrombophilia include factor V Leiden, prothrombin 20210, antiphospholipid syndrome, and others. Drugs used to treat thrombophilia include Heparin, Warfarin, and others, with various administration routes such as oral and parenteral. End-users of thrombophilia drugs include hospitals, home health agencies, specialty centers, and others.

Technological advancements are a key trend in the Thrombophilia market, with major companies focusing on developing innovative technologies to sustain their market position. For instance, in March 2022, Pfizer Inc. acquired Arena Pharmaceuticals, aiming to generate innovations to improve the lives of people suffering from immuno-inflammatory disorders and thromboembolic disorders of the arterial blood vessels.

North America was the largest region in the Thrombophilia market in 2022, and it is expected to witness steady growth during the forecast period. Key countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

An increase in the elderly population is expected to drive the growth of the Thrombophilia market. Thrombophilic risk factors are common in elderly adults and can lead to poor clinical outcomes. Therefore, the rise in the elderly population will boost the market, creating demand for thrombophilia drugs.

According to data released by America's Health Rankings, more than 56 million adults aged 65 and older accounted for around 16.9% of the total US population in 2022. This number is expected to increase to more than 73.1 million by 2030. As the last of the baby boomer generation enters old age, the elderly population is growing. Hence, the increase in the elderly population is driving the growth of the Thrombophilia market.

The Thrombophilia market consists of sales of rivaroxaban, apixaban, and thrombolytics. The market value includes the value of goods sold by the manufacturers or creators of the goods, whether to other entities or directly to end customers.

Key Topics Covered:

1. Executive Summary

2. Thrombophilia Market Characteristics

3. Thrombophilia Market Trends And Strategies

4. Thrombophilia Market - Macro Economic Scenario
4.1. COVID-19 Impact On Thrombophilia Market
4.2. Ukraine-Russia War Impact On Thrombophilia Market
4.3. Impact Of High Inflation On Thrombophilia Market

5. Thrombophilia Market Size And Growth
5.1. Global Thrombophilia Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Thrombophilia Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Thrombophilia Market Segmentation
6.1. Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Factor V Leiden
• Prothrombin 20210
• Antiphospholipid Syndrome
• Other Type

6.2. Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Heparin
• Warfarin
• Other Drugs

6.3. Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Oral
• Parenteral
• Other Route Of Administration

6.4. Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Hospitals
• Homecare
• Speciality Centres
• Other End Users

7. Thrombophilia Market Regional And Country Analysis
7.1. Global Thrombophilia Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Thrombophilia Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/195nsj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets